181 related articles for article (PubMed ID: 34797436)
1. The risk of diffuse-type gastric cancer following diagnosis with gastric precancerous lesions: a systematic review and meta-analysis.
Wang JE; Kim SE; Lee BE; Park S; Hwang JH; Huang RJ
Cancer Causes Control; 2022 Feb; 33(2):183-191. PubMed ID: 34797436
[TBL] [Abstract][Full Text] [Related]
2. Prevalence of gastric cancer precursors in gastroscopy-screened adults by family history of gastric cancer and of cancers other than gastric.
Wu R; Yang C; Ji L; Fan ZN; Tao YW; Zhan Q
BMC Cancer; 2020 Nov; 20(1):1110. PubMed ID: 33198658
[TBL] [Abstract][Full Text] [Related]
3. Comparison of operative link for gastritis assessment, operative link on gastric intestinal metaplasia assessment, and TAIM stagings among men with atrophic gastritis.
Nieminen AA; Kontto J; Puolakkainen P; Virtamo J; Kokkola A
World J Gastroenterol; 2020 Jun; 26(24):3447-3457. PubMed ID: 32655268
[TBL] [Abstract][Full Text] [Related]
4. Helicobacter pylori-related precancerous lesions in Turkey: a retrospective endoscopic surveillance study.
Bas B; Dinc B
Croat Med J; 2020 Aug; 61(4):319-325. PubMed ID: 32881429
[TBL] [Abstract][Full Text] [Related]
5. Gastro-duodenal disease in Africa: Literature review and clinical data from Accra, Ghana.
Archampong TN; Asmah RH; Richards CJ; Martin VJ; Bayliss CD; Botão E; David L; Beleza S; Carrilho C
World J Gastroenterol; 2019 Jul; 25(26):3344-3358. PubMed ID: 31341360
[TBL] [Abstract][Full Text] [Related]
6. Regulation of apoptosis is impaired in atrophic gastritis associated with gastric cancer.
Rosania R; Varbanova M; Wex T; Langner C; Bornschein J; Giorgio F; Ierardi E; Malfertheiner P
BMC Gastroenterol; 2017 Jun; 17(1):84. PubMed ID: 28662697
[TBL] [Abstract][Full Text] [Related]
7. [Reversibility of Atrophic Gastritis and Intestinal Metaplasia by Eradication of
Yoon K; Kim N
Korean J Gastroenterol; 2018 Sep; 72(3):104-115. PubMed ID: 30270592
[TBL] [Abstract][Full Text] [Related]
8. Predictors for regression and progression of intestinal metaplasia (IM): A large population-based study from low prevalence area of gastric cancer (IM-predictor trial).
Aumpan N; Vilaichone RK; Pornthisarn B; Chonprasertsuk S; Siramolpiwat S; Bhanthumkomol P; Nunanan P; Issariyakulkarn N; Ratana-Amornpin S; Miftahussurur M; Mahachai V; Yamaoka Y
PLoS One; 2021; 16(8):e0255601. PubMed ID: 34379655
[TBL] [Abstract][Full Text] [Related]
9. Incomplete Intestinal Metaplasia Is Rare in Autoimmune Gastritis.
Genta RM; Turner KO; Robiou C; Singhal A; Rugge M
Dig Dis; 2023; 41(3):369-376. PubMed ID: 36739859
[TBL] [Abstract][Full Text] [Related]
10. Outcome of intestinal metaplasia in gastric biopsy of patients with dyspepsia in Guilan Province, North Iran.
Mansour-Ghanaei F; Joukar F; Soati F; Mansour-Ghanaei A; Atrkar-Roushan Z
Asian Pac J Cancer Prev; 2013; 14(6):3549-54. PubMed ID: 23886143
[TBL] [Abstract][Full Text] [Related]
11. Determination of an Appropriate Endoscopic Monitoring Interval for Patients with Gastric Precancerous Conditions in China.
Zhao K; Feng LN; Xia SH; Zhou WD; Zhang MY; Zhang Y; Dong RN; Tian DA; Liu M; Liao JZ
Curr Med Sci; 2023 Apr; 43(2):268-273. PubMed ID: 36864248
[TBL] [Abstract][Full Text] [Related]
12. Prevalence and factors associated with atrophic gastritis and intestinal metaplasia: A multivariate, hospital-based, statistical analysis.
Chitapanarux T; Kongkarnka S; Wannasai K; Sripan P
Cancer Epidemiol; 2023 Feb; 82():102309. PubMed ID: 36470067
[TBL] [Abstract][Full Text] [Related]
13. Long-Term Follow-up of Gastric Precancerous Lesions in a Low GC Incidence Area.
Chapelle N; Péron M; Quénéhervé L; Bourget A; Leroy M; Touchefeu Y; Cauchin E; Coron E; Mosnier JF; Matysiak-Budnik T
Clin Transl Gastroenterol; 2020 Dec; 11(12):e00237. PubMed ID: 33512802
[TBL] [Abstract][Full Text] [Related]
14. Helicobacter pylori associated gastric intestinal metaplasia: Treatment and surveillance.
Liu KS; Wong IO; Leung WK
World J Gastroenterol; 2016 Jan; 22(3):1311-20. PubMed ID: 26811668
[TBL] [Abstract][Full Text] [Related]
15. Helicobacter pylori eradication cannot reduce the risk of gastric cancer in patients with intestinal metaplasia and dysplasia: evidence from a meta-analysis.
Chen HN; Wang Z; Li X; Zhou ZG
Gastric Cancer; 2016 Jan; 19(1):166-75. PubMed ID: 25609452
[TBL] [Abstract][Full Text] [Related]
16. The Colombian Chemoprevention Trial: 20-Year Follow-Up of a Cohort of Patients With Gastric Precancerous Lesions.
Piazuelo MB; Bravo LE; Mera RM; Camargo MC; Bravo JC; Delgado AG; Washington MK; Rosero A; Garcia LS; Realpe JL; Cifuentes SP; Morgan DR; Peek RM; Correa P; Wilson KT
Gastroenterology; 2021 Mar; 160(4):1106-1117.e3. PubMed ID: 33220252
[TBL] [Abstract][Full Text] [Related]
17. The Difference of Endoscopic and Histologic Improvements of Atrophic Gastritis and Intestinal Metaplasia After Helicobacter pylori Eradication.
Hwang YJ; Choi Y; Kim N; Lee HS; Yoon H; Shin CM; Park YS; Lee DH
Dig Dis Sci; 2022 Jul; 67(7):3055-3066. PubMed ID: 34365533
[TBL] [Abstract][Full Text] [Related]
18. Role of endoscopy in suspicion of atrophic gastritis with and without intestinal metaplasia in comparison to histopathology.
Ibrahim H; El-Deen AS; Kasemy ZA; Saad M; Sakr AA
Acta Gastroenterol Belg; 2021; 84(1):9-17. PubMed ID: 33639688
[TBL] [Abstract][Full Text] [Related]
19. Antral-type mucosa in the gastric incisura, body, and fundus (antralization): a link between Helicobacter pylori infection and intestinal metaplasia?
Xia HH; Kalantar JS; Talley NJ; Wyatt JM; Adams S; Chueng K; Mitchell HM
Am J Gastroenterol; 2000 Jan; 95(1):114-21. PubMed ID: 10638568
[TBL] [Abstract][Full Text] [Related]
20. Effectiveness of Helicobacter pylori eradication in preventing metachronous gastric cancer and preneoplastic lesions. A systematic review and meta-analysis.
Khan MY; Aslam A; Mihali AB; Shabbir Rawala M; Dirweesh A; Khan S; Adler DG; Siddiqui A
Eur J Gastroenterol Hepatol; 2020 Jun; 32(6):686-694. PubMed ID: 32355093
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
